AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Gluvoiz M 1mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Ellanjey Lifesciences

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Gluvoiz M 1mg/500mg Tablet SR

Diabetol Duo 1mg/500mg Extended-Release Tablets are antidiabetic medications combining two drugs to manage type 2 diabetes in adults. This combination helps regulate blood glucose. Diabetol Duo should be taken with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may adjust based on your blood sugar response. Continue taking this medication even if feeling well or if blood sugar is controlled; discontinuation without consulting your doctor risks elevated blood glucose, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. This medication is part of a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is the most frequent side effect, characterized by sweating, dizziness, headache, and tremors. Learn to recognize and treat hypoglycemia; maintain regular mealtimes and carry a rapid-acting glucose source like sugary snacks or juice. Alcohol increases hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections; weight gain may occur. Do not use Diabetol Duo if you have type 1 diabetes, diabetic ketoacidosis, or severe kidney/liver disease. Inform your doctor of any heart condition history before starting this medication; it may be unsuitable. Pregnant or breastfeeding individuals should consult their physician. Regular blood glucose monitoring and potential blood tests for blood cell counts and liver function are necessary.

Uses of Gluvoiz M 1mg/500mg Tablet SR

Managing Type 2 Diabetes

Major Benefits of Gluvoiz M 1mg/500mg Tablet SR:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the Gluvoiz M 1mg/500mg Tablet SR whole; avoid chewing, crushing, or fracturing. Consume this medication with a meal.

Common Side effects of Gluvoiz M 1mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Gluvoiz M 1mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Gluvoiz M 1mg/500mg Tablet SR whole; do not break, crush, or chew it. Consume this extended-release tablet with food.

How Gluvoiz M 1mg/500mg Tablet SR works:

Gluvoiz M 1mg/500mg extended-release tablets combine glimepiride and metformin, two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose output, retarding intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Gluvoiz M 1mg/500mg SR tablets with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Gluvoiz M 1mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against potential hazards before recommending this medication. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Gluvoiz M tablets (1mg/500mg) are contraindicated for breastfeeding mothers due to the potential for infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Gluvoiz M 1mg/500mg Tablet SR cautiously, potentially requiring dose modification. Severe kidney disease contraindicates its use. Consult your physician. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Gluvoiz M 1mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. For individuals with mild to moderate liver disease, a low initial dose is typically recommended; however, Gluvoiz M 1mg/500mg SR tablets are unsuitable for those with severe hepatic dysfunction.

What if you forget to take Gluvoiz M 1mg/500mg Tablet SR :

Should you forget a Gluvoiz M 1mg/500mg SR tablet, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Gluvoiz M 1mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Gluvoiz M 1mg/500mg Tablet SR

Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Gluvoiz M 1mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. Seek immediate medical attention and discontinue Gluvoiz M 1mg/500mg Tablet SR if these symptoms occur.
Gluvoiz M 1mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Gluvoiz M 1mg/500mg Tablet SR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Prolonged use of Gluvoiz M 1mg/500mg Tablet SR can lead to Vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and balance problems (ataxia). To mitigate this risk, annual supplemental Vitamin B12 is recommended by some researchers.
Gluvoiz M 1mg/500mg Tablet SR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Gluvoiz M 1mg/500mg SR tablets with alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Gluvoiz M 1mg/500mg Table...
29
MRP 35
17% off